Cresco Labs Inc.

As interest rates climb and regulatory uncertainties loom, decisions on capital expenditures (capex) by cannabis MSOs (Multi-State Operators) become paramount for their future success. Are some MSOs missing out on significant growth opportunities? In his latest analysis, Pablo Zuanic, managing...

Cannabis companies Cresco Labs (OTC: CRLBF) and Columbia Care (OTC: CCHWF) will not be able to finalize their proposed multibillion-dollar merger due to regulatory hurdles. The Chicago-based companies failed to meet the June 30 deadline set in their agreement. They are now working together to...

Cantor Fitzgerald's Pablo Zuanic took a close look at the scenarios and permutations of the Cresco/Columbia Care deal. Cresco announced it was acquiring its rival Columbia Care for $2.1 billion in March 2022. Once the deal is finalized, Cresco Labs will become the largest...